Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
167.00    2.00 (1.21%)
Bid:
165.50
Ask:
168.50
Spread: 3.00 (1.813%)
Market Cap: £32.61m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Share Buyback Programme

17 Apr 2026 07:00

RNS Number : 8371A
Palace Capital PLC
17 April 2026
 

LEI:2138009JDFQOXJFCJQ05

17 April 2026

Palace Capital PLC

 ("Palace Capital" or the "Company") 

Share Buyback Programme

The Board of Directors (the "Board") of Palace Capital announces it has approved a share buyback programme of up to 400,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") (the "Buyback Programme") as the initial step of a wider capital return programme it is progressing with its advisers.

The Company has instructed Cavendish to conduct the Buyback Programme on its behalf on a broker-managed basis, with trading decisions taken independently of the Company based parameters set by the Board. The Buyback Programme commences today and will end no later than six months from today, on 17 October 2026, or earlier if the maximum number of Ordinary Shares has been reached or the Company's buyback authority is not renewed at or before its next annual general meeting.

The Buyback Programme will be conducted in accordance with the terms of the Company's authority to make market purchases of its own Ordinary Shares granted to it by shareholders on 9 July 2025 (the "Authority"), including that the price paid per Ordinary Share will not be less than the nominal value of the Ordinary Shares, and the maximum price paid per Ordinary Share (excluding expenses) will be no more than the higher of either 105 per cent. of the average middle market closing price of an Ordinary Share as shown on the Daily Official List for the five business days preceding the date of any buyback; and an amount equal to the higher of the price of the last independent trade of an Ordinary Share and the highest current independent bid for an Ordinary Share on the trading venue where the purchase is carried out.

The Authority will expire on 9 October 2025 or, if earlier, at the conclusion of the Company's next annual general meeting ("AGM"), at which a proposal (amongst others) will be put to shareholders to renew the Company's ability to make market purchases of its Ordinary Shares. Accordingly, the Buyback Programme will continue after that date pursuant to such renewed authority and will be conditional on the approval of the same by shareholders. The Company intends to hold all Ordinary Shares so purchased in treasury during the course of the Buyback Programme and, following completion of the Buyback Programme, will seek to cancel the Ordinary Shares.

Due to the limited liquidity in the issued Ordinary Shares, a buyback of Ordinary Shares pursuant to the Authority (or its successor) on any given trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and could exceed 25 per cent. of the average daily trading volume and, accordingly, the Company will not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014 as adopted into UK law by the European Union (Withdrawal) Act 2018.

The Company will make further announcements in due course following any share purchases under the Buyback Programme.

 

Enquiries:

 

Palace Capital plcChristian Kappelhoff-Wulff, Non-Executive Chairmanckw@palacecapitalplc.com

Financial PR

FTI ConsultingDido Laurimore / Andrew Davis

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

 

Broker

Cavendish

Matt Lewis, Head of Corporate BrokingTel: +44 (0)20 7397 1920mlewis@cavendish.com

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNVBRNRUSAAR
Date   Source Headline
20th Jan 20224:40 pmRNSSecond Price Monitoring Extn
20th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSAcquisition of Maidenhead office building
20th Dec 20217:00 amRNSDisposal strategy nears completion
16th Dec 20217:00 amRNSAppointment of new Chairman
15th Dec 202110:46 amEQSHardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
9th Dec 20217:00 amRNSLetting of office space at Hudson Quarter, York
6th Dec 20217:00 amRNSSale of Staines Office Building
3rd Dec 202112:40 pmEQSHardman & Co Research : Palace Capital (PCA) - Interim results: ammunition for major dividend rises
29th Nov 20217:00 amRNSDisposal strategy continues with Aldershot sale
18th Nov 20217:00 amRNSDirector Dealing
17th Nov 20211:04 pmRNSINVESTOR PRESENTATION
16th Nov 20217:00 amRNSInterim Results
12th Nov 202110:30 amRNSHolding(s) in Company
12th Nov 20217:00 amRNSAppointment of Matthew Simpson as CFO
26th Oct 20217:00 amRNSUpdate on Chair recruitment
19th Oct 20217:00 amRNSTrading Update
4th Oct 20214:35 pmRNSPrice Monitoring Extension
30th Sep 20214:41 pmRNSSecond Price Monitoring Extn
30th Sep 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20217:00 amRNSHolding(s) in Company
30th Sep 20217:00 amRNSDisposal of Holding in Circle Property Plc
20th Aug 20214:10 pmRNSDirector Dealing
13th Aug 20211:00 pmRNSDirectorate Change
29th Jul 20214:30 pmRNSResult of AGM
27th Jul 20217:00 amRNSChairman retirement & strategy update
19th Jul 20217:00 amRNSDisposal programme continues with Weybridge sale
14th Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20219:00 amEQSHardman & Co Research : Hardman Talks Video | Palace Capital Management Presentation
23rd Jun 20211:45 pmRNSAnnual Report and Notice of Annual General Meeting
21st Jun 202111:30 amEQSHardman & Co Research: Palace Capital (PCA): Dividend recovery ahead of expectations
16th Jun 202110:52 amRNSDirector Dealing
9th Jun 20214:10 pmEQSHardman & Co Research : Hardman Talks Video Event | Palace Capital Management Presentation
8th Jun 20217:00 amRNSFinal Results for the year ended 31 March 2021
1st Jun 20214:03 pmRNSNotice of Results & Investor Presentation
14th May 20215:18 pmRNSDirector Declaration
22nd Apr 20214:40 pmEQSHardman & Co Research: Palace Capital (PCA): Strong trading update
14th Apr 20217:00 amRNSTrading update
19th Mar 20215:48 pmRNSDirector/PDMR Shareholding
10th Mar 20219:05 amRNSDividend Declaration
5th Mar 20212:22 pmRNSHolding(s) in Company
17th Feb 20212:43 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSUpdate on rent collection
21st Dec 202012:05 pmEQSHardman & Co Research: Q&A with Mike Foster on Palace Capital (PCA): Interim results on track - upside clear in FY'22
26th Nov 20208:00 amEQSPalace Capital (PCA): COVID-19 impacts actively managed
24th Nov 20205:20 pmEQSHardman & Co Research: Palace Capital (PCA): Interim results on track - upside clear in FY'22
17th Nov 20207:00 amRNSHalf-year Report
13th Nov 20207:00 amRNSInvestor Presentation
26th Oct 20203:00 pmRNSDirector/PDMR Shareholding
16th Oct 20202:09 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.